Vivo Bio Tech Ltd appointed Bhavish Vijayvargiya as Company Secretary and Compliance Officer effective June 24, 2026, following the resignation of Mr. A V Kiran. The Board of Directors approved the appointment during a meeting held on June 24, 2026, which commenced at 4:00 P.M. and concluded at 4:20 P.M. Mr. A V Kiran resigned to pursue alternate career opportunities outside the organization and was relieved from his responsibilities with effect from June 24, 2026.

Mr. Bhavish Vijayvargiya has been designated as a Whole-Time Key Managerial Personnel (KMP) of the company. He is an Associate Member of the Institute of Company Secretaries of India, holding Membership No. A77631. His experience includes core areas of Corporate Secretarial functions and Compliance management.

The appointment was made pursuant to Section 203 of the Companies Act 2013 and Regulation 6(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosures were made in compliance with Regulation 30 read with Part A, Para A of Schedule III of the SEBI Regulations, 2015 and SEBI Circular No SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The company subsequently submitted a clarification to BSE Limited on June 29, 2026, regarding the inadvertent omission of the Board meeting commencement and conclusion times in the initial announcement.

Details of Appointment and Resignation

The following table outlines the key details regarding the change in the Company Secretary and Compliance Officer position:

The Board has authorised Mr. Bhavish Vijayvargiya to determine the materiality of an event or information and for advising on disclosures to the stock exchanges. The contact details for the authorized person are provided below:

Name: Bhavish Vijayvargiya Designation: Company Secretary & Compliance Officer Address: 3rd Floor, Ilyas Mohammed Khan Estate#8-2-672/5 & 6, Road No. 1, Banjara Hills, Hyderabad, Telangana – 500034. Email: investor@vivobio.com Phone: 040-23313288

Vivo Bio Tech has initiated a postal ballot process seeking shareholder approval for the re-appointment of a Whole-time Director and two related party transactions, including a potential annual engagement worth ₹30 crore with Virinchi Limited. The company has scheduled remote e-voting from June 15, 2026, to July 14, 2026, to pass resolutions on these matters, which are critical for its strategic leadership and operational continuity.

The first resolution seeks the re-appointment of Mr. Kalyan Ram Mangipudi (DIN: 02012580) as Whole-time Director. His remuneration is proposed to be a consolidated salary of up to ₹1,00,000 per month, with the Board authorized to revise the gross salary by a maximum of 50% per annum. The company stated that the remuneration will comply with the limits under Sections 197 and 198 of the Companies Act, 2013, and Schedule V thereto.

Shareholders will also vote on appointing Mrs. Madhavi Latha Kompella, a Promoter, as an Advisor for Strategy & Business Development for a term of five years from October 01, 2026, to September 30, 2031. The appointment involves a fixed fee of ₹15,00,000 per month and reimbursement of actual expenses incurred for travel and lodging. The company noted that this transaction is material, representing approximately 3.37% of the annual consolidated turnover for FY 2025-26.

The third resolution requests approval for material related party transactions with Virinchi Limited, where Vivo Bio Tech holds a 5.38% stake. The company seeks approval to enter into transactions involving the availing of software consultancy services and the transfer of resources or inter-corporate loans. The aggregate value of these transactions shall not exceed ₹30,00,00,000 during a financial year. Inter-corporate loans, if any, will carry an interest rate of approximately 9% per annum and be repayable within 12 months.

The Board of Directors has appointed Mr. G. Vinay Babu, Practicing Company Secretary, as the Scrutinizer to ensure the voting process is conducted fairly. The results of the postal ballot will be declared on or before Thursday, July 16, 2026. The cut-off date for determining shareholder eligibility to vote is Friday, June 05, 2026.

The notice was dispatched to members on June 12, 2026. Advertisements pertaining to the Notice of Postal Ballot & E-Voting were published in the Financial Express and Nava Telangana on June 13, 2026. Shareholders can cast their votes electronically through the CDSL e-voting system during the designated window.